These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12734414)

  • 1. PARC: a potential target for cancer therapy.
    Nikolaev AY; Gu W
    Cell Cycle; 2003; 2(3):169-71. PubMed ID: 12734414
    [No Abstract]   [Full Text] [Related]  

  • 2. Parc-ing p53 in the cytoplasm.
    Kastan MB; Zambetti GP
    Cell; 2003 Jan; 112(1):1-2. PubMed ID: 12526785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
    Zhang Y; Xiong Y
    Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parc: a cytoplasmic anchor for p53.
    Nikolaev AY; Li M; Puskas N; Qin J; Gu W
    Cell; 2003 Jan; 112(1):29-40. PubMed ID: 12526791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the p53 pathway by ubiquitin and related proteins.
    Hock A; Vousden KH
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1618-21. PubMed ID: 20601087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
    Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
    Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53: 25 years of research and more questions to answer.
    Bourdon JC; Laurenzi VD; Melino G; Lane D
    Cell Death Differ; 2003 Apr; 10(4):397-9. PubMed ID: 12719714
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional significance of minor structural and expression changes in stress chaperone mortalin.
    Deocaris CC; Widodo N; Ishii T; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2007 Nov; 1119():165-75. PubMed ID: 18056964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells.
    Athanassiou M; Hu Y; Jing L; Houle B; Zarbl H; Mikheev AM
    Cell Growth Differ; 1999 Nov; 10(11):729-37. PubMed ID: 10593649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The positive regulation of p53 by the tumor suppressor VHL.
    Roe JS; Youn HD
    Cell Cycle; 2006 Sep; 5(18):2054-6. PubMed ID: 16969113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53: more research and more questions.
    Braithwaite AW; Prives CL
    Cell Death Differ; 2006 Jun; 13(6):877-80. PubMed ID: 16708075
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation and function of the p53 tumor suppressor protein.
    Ryan KM; Phillips AC; Vousden KH
    Curr Opin Cell Biol; 2001 Jun; 13(3):332-7. PubMed ID: 11343904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53--guardian of a genome's guardian?
    Rubbi CP; Milner J
    Cell Cycle; 2003; 2(1):20-1. PubMed ID: 12695679
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving cancer therapy through p53 management.
    Haupt S; Haupt Y
    Cell Cycle; 2004 Jul; 3(7):912-6. PubMed ID: 15254405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
    Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S
    Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP).
    Rolfe M; Beer-Romero P; Glass S; Eckstein J; Berdo I; Theodoras A; Pagano M; Draetta G
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3264-8. PubMed ID: 7724550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdm2-SUMO1: is bigger better?
    Melchior F; Hengst L
    Nat Cell Biol; 2000 Sep; 2(9):E161-3. PubMed ID: 10980713
    [No Abstract]   [Full Text] [Related]  

  • 19. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
    Rodríguez JA
    Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.